FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileDrägerwerk AG & Co. KGaA
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
DRWKF
Drägerwerk AG & Co. KGaA Stock AnalysisComprehensive stock analysis for Drägerwerk AG & Co. KGaA (DRWKF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisDRWKF
DRWKF
Drägerwerk AG & Co. KGaA
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
DRWKF
Home🔹Stocks🔹Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA

🇺🇸DRWKF•OTC

Drägerwerk AG & Co. KGaA

🇺🇸DRWKF•OTC
Market cap
$2.08B
Sentiment

Your view on DRWKF

Mkt Cap
$2.08B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Drägerwerk AG & Co. KGaA

Industry
Medical - Devices
Sector
Healthcare
CEO
Stefan A. Drager
Headquarters
Moislinger Allee 53-55, Lübeck, DE
Industry
Medical - Devices
Sector
Healthcare
CEO
Stefan A. Drager
Headquarters
Moislinger Allee 53-55, Lübeck, DE
Description

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection.

The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services.

Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices.

In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

Fair value for Drägerwerk AG & Co. KGaA from FRC's valuation model, read against the market price. DRWKF last traded at $111.00, 12.1× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Drägerwerk AG & Co. KGaA. Starting points for Drägerwerk AG & Co. KGaA: P/E 12.1, EPS $9.04, beta 0.71 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Drägerwerk AG & Co. KGaA. Drägerwerk AG & Co. KGaA does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Drägerwerk AG & Co. KGaA. Trailing twelve-month EPS for Drägerwerk AG & Co. KGaA stands at $9.04. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

As of Nov 12, 2026 · EUR

Earnings Estimate

EPSCurrent QtrDec 2026Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimateEUR 0.00EUR 8.16EUR 8.70
Low estimateEUR 0.00EUR 7.92EUR 8.44
High estimateEUR 0.00EUR 8.28EUR 8.83
No. of analysts011
Year-ago EPSEUR 5.05EUR 7.44—
Growth-100.0%+9.7%—

Revenue Estimate

RevenueCurrent QtrDec 2026Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimateEUR 1.22BEUR 3.62BEUR 3.77B
Low estimateEUR 1.22BEUR 3.56BEUR 3.66B
High estimateEUR 1.22BEUR 3.65BEUR 3.81B
No. of analysts166
Year-ago revenueEUR 1.14BEUR 3.48B—
Growth+6.9%+3.9%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 12, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Drägerwerk AG & Co. KGaA. Drägerwerk AG & Co. KGaA has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Drägerwerk AG & Co. KGaA valued side by side against its closest peers. Drägerwerk AG & Co. KGaA is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

News

Latest headlines and market coverage.

Latest headlines and company announcements for Drägerwerk AG & Co. KGaA. Coverage tracks Drägerwerk AG & Co. KGaA within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Drägerwerk AG & Co. KGaA.

More Medical - Devices companies

  • BBNXBeta Bionics, Inc.
  • BCCOYBICO Group AB (publ)
  • BDMDBaird Medical Investment Holdings Limited
  • BFLYButterfly Network, Inc.
  • BIIOBionovate Technologies Corp
  • BIOBio-Rad Laboratories, Inc.
  • BIO-BBio-Rad Laboratories, Inc.
  • BJDXBluejay Diagnostics, Inc.
  • BMRABiomerica, Inc.
  • BRKRBruker Corporation
  • BRKRPBruker Corporation
  • BRNHFBroncus Holding Corporation

ETFs holding Drägerwerk AG & Co. KGaA

Largest holders, then the funds most concentrated in DRWKF · % = share of the fund

  • VIU.TOVanguard FTSE Developed All Cap ex North America Index ETF0.00%
  • VEQT.TOVanguard All-Equity ETF Portfolio0.00%
  • VGRO.TOVanguard Growth ETF Portfolio0.00%
  • VE.TOVanguard FTSE Developed Europe All Cap Index ETF0.01%
  • VEF.TOVanguard FTSE Developed All Cap ex U.S. Index ETF (CAD-hedged)0.00%
  • VI.TOVanguard FTSE Developed All Cap ex North America Index ETF (CAD-hedged)0.00%
  • VXC.TOVanguard FTSE Global All Cap ex Canada Index ETF0.00%
  • VBAL.TOVanguard Balanced ETF Portfolio0.00%
DRWKF Analysis
Good
Past5
Growth3
Health4
Profit3
Value3

News

Latest Market News